Search database
LIST OPTIONS
Filter
29
Filtered Results: 29
Text search: vaxzevria
Featured
Language
Document type
Guidelines
17
Fact sheets
7
Studies & Reports
4
No document type
1
Countries / Regions
Ukraine
3
Brazil
3
Latin America and the Carribbean
2
Germany
2
Authors & Publishers
World Health Organization WHO
12
OPAS
3
Organización Mundial de la Salud OMS
2
World Health Organisation (WHO)
2
Access to Medicine Foundation
1
Africa CDC Centres for Disease Control and Prevention
1
African Union
1
European Centre for Disease Prevention and Control ECDC
1
European Medicines Agency EMA
1
Health Cluster, WHO
1
OPAS, OMS
1
Organisation Mondiale de la Santé OMS
1
Organización Panamericana de la Salud
1
Organização Mundial da Saúde (OMS)
1
PAHO
1
Pan American Health Organisation PAHO
1
Robert-Koch-Institut RKI
1
Vygen-Bonnet S, Koch J, Bogdan C, et al.
1
WHO
1
WHO Europe
1
World Health Organization WHO, Regional Office of Europe
1
Publication Years
Category
COVID-19
6
Guidelines
3
Vaccine-preventable Diseases
2
Humanitarian Crisis
2
Policies
1
Studies & Reports
1
Pharmacy & Technologies
1
Toolboxes
Immunization Guidelines
9
Clinical Guidelines
7
Vaxzevria (Astra Zeneca)
6
Access & Strategy
4
SARS-CoV-2 Variants
2
Booster Doses
2
Situation Reports & Updates
2
Guidelines & Manuals
2
Europe
1
Vaccination
1
Pediatrics
1
Context & Facts, Travel Advice
1
For Parents & Children
1
For Pregnant Women
1
For People with Disabilities
1
Country specific documents
1
For Older People
1
Long-term Care Facilities
1
Fair Allocation & Ethical Aspects
1
COVAX Initiative
1
Long COVID/ Post-COVID Syndrome
1
Moderna
1
Biontech/Pfizer Comirnaty
1
Johnson & Johnson
1
Research & Pipeline
1
Essential Medicines
1
Prices and Patents
1
Reports & Studies
1
General
1
Global Overview
1
Human Rights & the Right to Health
1
Overview 16 Dec 2021. This interim guidance pertains to heterologous primary and heterologous boosting schedules of Covid-19 vaccines. It focuses on heterologous schedules combining multiple vaccine platforms (e.g. a vectored vaccine followed by an mRNA vaccine).
Guidance for clinical case management of thrombosis syndrome with thrombocytopenia (TTS) following vaccination to prevent coronavirus disease (COVID-19) Interim guidance 19 July 2021
Neurology and COVID-19. Scientific report 29 September 2021
8 March 2022 A very large number of people from Ukraine are fleeing the country and entering the European Union (EU) countries bordering Ukraine (Hungary, Poland, Romania, Slovakia) and the EU-neighbourhood country of the Republic of Moldova. Those fleeing Ukraine - mainly women and children - are ... more
This document provides guidance on interventions to prevent vaccine-preventable disease outbreaks in the context of mass population movement resulting from the ongoing crisis in Ukraine.
The report aims to capture lessons from the COVID-19 pandemic and to highlight the opportunity for more ambitious global action: expanding sustainable access to vaccines for all towards the Immunization Agenda 2030 and pandemic prevention, preparedness and response efforts. The report is organized ... more
The WHO Pharmaceuticals Newsletter provides you with the latest information on the safety of medicinal products and regulatory actions taken by authorities around the world. In addition, this edition includes summary and recommendations from the virtual meeting of the members of the WHO Programme f... more
The report aims to capture lessons from the COVID-19 pandemic and to highlight the opportunity for more ambitious global action: expanding sustainable access to vaccines for all towards the Immunization Agenda 2030 and pandemic prevention, preparedness and response efforts. The report is organized i... more